Brexit denies UK children access to life-extending drug for aggressive brain cancer

Exclusive: Experts say Brexit has led to delays in the launch of clinical trials and increased costs for multiple drugs.

They are urging the government https://www.independent.co.uk/topic/government">to reset the UK’s relationship with Europe to reopen access to potentially life-changing treatments